Search details
1.
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.
Future Oncol
; 20(12): 761-780, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38231045
2.
Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting.
Future Oncol
; 19(28): 1905-1916, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37497677
3.
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
Gastric Cancer
; 21(5): 831-844, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29397460
4.
Bringing care home: how telemonitoring can expand population health management beyond the hospital.
Nurs Adm Q
; 38(2): 166-72, 2014.
Article
in English
| MEDLINE | ID: mdl-24569764
5.
Should intussusception in children prompt screening for celiac disease?
J Pediatr Gastroenterol Nutr
; 56(1): 56-9, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22832512
6.
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.
Target Oncol
; 18(4): 543-558, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37428347
7.
Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation.
Dermatol Ther (Heidelb)
; 12(5): 1211-1224, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35507216
8.
Pembrolizumab Utilization and Clinical Outcomes Among Patients With Advanced Melanoma in the US Community Oncology Setting: An Updated Analysis.
J Immunother
; 44(6): 224-233, 2021.
Article
in English
| MEDLINE | ID: mdl-33734142
9.
An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF-mutant advanced melanoma treated with first-line anti-PD-1 monotherapies or BRAF/MEK inhibitors in a community-based oncology setting.
Cancer Med
; 9(21): 7863-7878, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32871054
10.
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
Clinicoecon Outcomes Res
; 12: 645-656, 2020.
Article
in English
| MEDLINE | ID: mdl-33192078
11.
Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article).
Medicine (Baltimore)
; 98(28): e16328, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31305421
12.
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study.
Clin Ther
; 41(5): 866-881.e7, 2019 05.
Article
in English
| MEDLINE | ID: mdl-31030993
13.
A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting.
Ther Adv Hematol
; 10: 2040620718816699, 2019.
Article
in English
| MEDLINE | ID: mdl-30719266
14.
Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis.
Adv Ther
; 35(11): 1905-1919, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30341504
15.
Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence.
J Manag Care Spec Pharm
; 21(8): 670-7, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26233539
16.
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.
Am Health Drug Benefits
; 8(5): 263-71, 2015.
Article
in English
| MEDLINE | ID: mdl-26380032
Results
1 -
16
de 16
1
Next >
>>